HRP20110558T1 - Malatne soli i polimorfi od (3s, 5s)-7-[3-amino-5-metil-piperidinil]-1-ciklopropil-1, 4-dihidro-8-metoksi-4-okso-3-kinolinkarboksilne kiseline - Google Patents
Malatne soli i polimorfi od (3s, 5s)-7-[3-amino-5-metil-piperidinil]-1-ciklopropil-1, 4-dihidro-8-metoksi-4-okso-3-kinolinkarboksilne kiseline Download PDFInfo
- Publication number
- HRP20110558T1 HRP20110558T1 HR20110558T HRP20110558T HRP20110558T1 HR P20110558 T1 HRP20110558 T1 HR P20110558T1 HR 20110558 T HR20110558 T HR 20110558T HR P20110558 T HRP20110558 T HR P20110558T HR P20110558 T1 HRP20110558 T1 HR P20110558T1
- Authority
- HR
- Croatia
- Prior art keywords
- salt
- malate
- image
- hydrate
- pattern
- Prior art date
Links
- 150000004701 malic acid derivatives Chemical class 0.000 title claims 10
- AVPQPGFLVZTJOR-RYUDHWBXSA-N nemonoxacin Chemical compound COC1=C(N2C[C@@H](N)C[C@H](C)C2)C=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 AVPQPGFLVZTJOR-RYUDHWBXSA-N 0.000 title claims 3
- 150000003839 salts Chemical class 0.000 claims abstract 35
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract 15
- BJEPYKJPYRNKOW-UWTATZPHSA-N (R)-malic acid Chemical compound OC(=O)[C@H](O)CC(O)=O BJEPYKJPYRNKOW-UWTATZPHSA-N 0.000 claims 7
- 238000002441 X-ray diffraction Methods 0.000 claims 4
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 claims 2
- 238000002329 infrared spectrum Methods 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- QSVWKBUDZWXCAX-HSHFZTNMSA-N (2R)-2-hydroxybutanedioic acid hydrate Chemical compound O.C([C@H](O)CC(=O)O)(=O)O QSVWKBUDZWXCAX-HSHFZTNMSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- -1 (3S, 5S) -7- [3-Amino-5-methyl-piperidinyl] -1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid malate salt Chemical class 0.000 abstract 4
- QSVWKBUDZWXCAX-DKWTVANSSA-N O.O[C@@H](CC(O)=O)C(O)=O Chemical compound O.O[C@@H](CC(O)=O)C(O)=O QSVWKBUDZWXCAX-DKWTVANSSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78648306P | 2006-03-28 | 2006-03-28 | |
| PCT/IB2007/051055 WO2007110834A2 (en) | 2006-03-28 | 2007-03-26 | Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110558T1 true HRP20110558T1 (hr) | 2011-09-30 |
Family
ID=38441484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110558T HRP20110558T1 (hr) | 2006-03-28 | 2011-07-26 | Malatne soli i polimorfi od (3s, 5s)-7-[3-amino-5-metil-piperidinil]-1-ciklopropil-1, 4-dihidro-8-metoksi-4-okso-3-kinolinkarboksilne kiseline |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8039485B2 (ja) |
| EP (1) | EP2001862B1 (ja) |
| JP (1) | JP5097967B2 (ja) |
| KR (1) | KR101102288B1 (ja) |
| AR (2) | AR060189A1 (ja) |
| AT (1) | ATE507219T1 (ja) |
| AU (1) | AU2007230630B2 (ja) |
| BR (1) | BRPI0709772B8 (ja) |
| CA (1) | CA2647346C (ja) |
| CY (1) | CY1111683T1 (ja) |
| DE (1) | DE602007014191D1 (ja) |
| DK (1) | DK2001862T3 (ja) |
| ES (1) | ES2366150T3 (ja) |
| HR (1) | HRP20110558T1 (ja) |
| IL (1) | IL193990A (ja) |
| MA (1) | MA30554B1 (ja) |
| MX (1) | MX2008012328A (ja) |
| MY (1) | MY148393A (ja) |
| NZ (1) | NZ570494A (ja) |
| PE (1) | PE20080175A1 (ja) |
| PL (1) | PL2001862T3 (ja) |
| PT (1) | PT2001862E (ja) |
| SI (1) | SI2001862T1 (ja) |
| SM (1) | SMP200800058B (ja) |
| TW (1) | TWI364419B (ja) |
| WO (1) | WO2007110834A2 (ja) |
| ZA (1) | ZA200807158B (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2008012488A (es) * | 2006-03-28 | 2008-10-10 | Procter & Gamble | Un proceso de acoplamiento para preparar intermedios de quinolona. |
| US8658183B2 (en) * | 2007-08-09 | 2014-02-25 | Taigen Biotechnology Company, Ltd. | Antimicrobial parenteral formulation |
| TR201820964T4 (tr) * | 2008-07-01 | 2019-01-21 | Taigen Biotechnology Co Ltd | Antibiyotiğe karşı dirençli bakteri enfeksiyonunun tedavisi. |
| CN101618039B (zh) * | 2008-07-02 | 2012-04-11 | 太景生物科技股份有限公司 | 肺炎的治疗药物 |
| US8553466B2 (en) | 2010-03-04 | 2013-10-08 | Samsung Electronics Co., Ltd. | Non-volatile memory device, erasing method thereof, and memory system including the same |
| CZ304983B6 (cs) * | 2012-10-12 | 2015-03-11 | Zentiva, K.S. | Způsob výroby a nové intermediáty syntézy elvitegraviru |
| CZ304984B6 (cs) | 2012-10-12 | 2015-03-11 | Zentiva, K.S. | Zlepšený způsob výroby a nové intermediáty syntézy elvitegraviru |
| CN103145615B (zh) * | 2013-03-20 | 2015-07-29 | 浙江医药股份有限公司 | 一种奈诺沙星螯合物的后处理方法 |
| CN114437026A (zh) * | 2021-10-26 | 2022-05-06 | 浙江医药股份有限公司新昌制药厂 | 一种低组合物杂质的苹果酸奈诺沙星原料药及其制备方法 |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4017622A (en) | 1972-12-18 | 1977-04-12 | Dainippon Pharmaceutical Co., Ltd. | Piperazine derivatives |
| JPS5186476A (en) | 1975-01-17 | 1976-07-29 | Yoshitomi Pharmaceutical | Shinkina kinoronkarubonsanjudotaino seiho |
| JPS5845426B2 (ja) | 1978-09-29 | 1983-10-08 | 杏林製薬株式会社 | 置換キノリンカルボン酸誘導体 |
| JPS604820B2 (ja) | 1979-02-26 | 1985-02-06 | 大塚製薬株式会社 | キノリンカルボン酸誘導体 |
| JPS5649382A (en) | 1979-09-28 | 1981-05-02 | Dainippon Pharmaceut Co Ltd | 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt |
| US5281612A (en) | 1982-09-09 | 1994-01-25 | Warner-Lambert Company | Naphthyridine antibacterial agents |
| US4665079A (en) | 1984-02-17 | 1987-05-12 | Warner-Lambert Company | Antibacterial agents |
| IE55898B1 (en) | 1982-09-09 | 1991-02-14 | Warner Lambert Co | Antibacterial agents |
| DE3248506A1 (de) | 1982-12-29 | 1984-07-05 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| US4994599A (en) | 1987-11-20 | 1991-02-19 | Abbott Laboratories | Intermediates for producing quinolone-3-carboxylic acids |
| JPS60221484A (ja) | 1984-04-17 | 1985-11-06 | Fuji Photo Film Co Ltd | 放射線像変換方法およびその方法に用いられる放射線像変換パネル |
| DE3420798A1 (de) | 1984-06-04 | 1985-12-05 | Bayer Ag, 5090 Leverkusen | 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren |
| US4822801A (en) | 1984-07-20 | 1989-04-18 | Warner-Lambert Company | 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents |
| US4771054A (en) | 1985-01-23 | 1988-09-13 | Warner-Lambert Company | Antibacterial agents |
| JPS61205258A (ja) | 1985-03-08 | 1986-09-11 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体及びその製造方法 |
| JPS61225181A (ja) | 1986-02-04 | 1986-10-06 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体及びその製造方法 |
| HUT40639A (en) | 1985-03-08 | 1987-01-28 | Kyorin Seiyaku Kk | Process for producing quinolon-carboxylic acid derivative and pharmaceutical composition containing them |
| ATE75740T1 (de) | 1985-06-26 | 1992-05-15 | Daiichi Seiyaku Co | Pyridoncarbonsaeurederivate. |
| JPS6236377A (ja) | 1985-07-03 | 1987-02-17 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体 |
| JPH089597B2 (ja) | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
| DE3705621C2 (de) | 1986-02-25 | 1997-01-09 | Otsuka Pharma Co Ltd | Heterocyclisch substituierte Chinoloncarbonsäurederivate |
| JPS62205060A (ja) | 1986-03-04 | 1987-09-09 | Kyorin Pharmaceut Co Ltd | ８位置換キノロンカルボン酸誘導体 |
| JPS62215572A (ja) | 1986-03-17 | 1987-09-22 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体 |
| JPH0717608B2 (ja) | 1986-04-25 | 1995-03-01 | 杏林製薬株式会社 | ６−アルコキシキノロンカルボン酸誘導体 |
| DE3704907A1 (de) | 1987-02-17 | 1988-08-25 | Bayer Ag | Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden |
| US4780468A (en) | 1987-08-07 | 1988-10-25 | Warner-Lambert Company | 8-trifluoromethyl quinolones as antibacterial agents |
| US4997946A (en) | 1987-08-18 | 1991-03-05 | Eastman Kodak Company | Process for the iodination of hydroxyaromatic and aminoaromatic compounds |
| JPH0676400B2 (ja) | 1987-08-25 | 1994-09-28 | 大日本製薬株式会社 | 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩 |
| US4921857A (en) | 1987-09-18 | 1990-05-01 | Merck & Co., Inc. | 4-Oxo-4h-quinolizine-3-carboxylic acids and derivatives thereof |
| US4920120A (en) | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
| DE68920773T2 (de) | 1988-05-19 | 1995-05-18 | Chugai Pharmaceutical Co Ltd | Chinoloncarbonsäure-Derivate. |
| JP2844079B2 (ja) | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
| DE3906365A1 (de) | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| FI95130C (fi) | 1988-07-20 | 1995-12-27 | Sankyo Co | Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi |
| US5286723A (en) | 1988-08-31 | 1994-02-15 | Daiichi Seiyaku Co., Ltd. | Spiro compound |
| EP0997466A1 (en) | 1988-10-24 | 2000-05-03 | PROCTER & GAMBLE PHARMACEUTICALS, INC. | Novel antimicrobial lactam-quinolones |
| CA2001203C (en) | 1988-10-24 | 2001-02-13 | Thomas P. Demuth, Jr. | Novel antimicrobial dithiocarbamoyl quinolones |
| US5328908A (en) | 1988-10-24 | 1994-07-12 | Procter & Gamble Pharmaceuticals, Inc. | Antimicrobial quinolone thioureas |
| PL166381B1 (pl) | 1989-08-16 | 1995-05-31 | Pfizer | Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL |
| US5164402A (en) | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
| CA2036516A1 (en) | 1990-02-19 | 1991-08-20 | Yoshikazu Asahina | Optically active 8-methoxyouinolonecarboxylic acid derivatives, their preparative processes and their intermediates |
| US5116834A (en) | 1990-04-12 | 1992-05-26 | Warner-Lambert Company | Quinolinecarboxylic acid antibacterial agents |
| US5599816A (en) | 1990-05-02 | 1997-02-04 | Abbott Laboratories | Quinolizinone type compounds |
| US5580872A (en) | 1990-05-02 | 1996-12-03 | Abbott Laboratories | Quinolizinone type compounds |
| CA2081891C (en) | 1990-05-02 | 1999-03-16 | Daniel T. Chu | Quinolizinone type compounds |
| JPH0778065B2 (ja) | 1990-07-06 | 1995-08-23 | 杏林製薬株式会社 | （６，７―置換―８―アルコキシ―１―シクロプロピル―１，４―ジヒドロ―４―オキソ―３―キノリンカルボン酸―ｏ▲上３▼，ｏ▲上４▼）ビス（アシルオキシ―ｏ）ホウ素化合物及びその塩並びにその製造方法 |
| US5258528A (en) | 1990-11-30 | 1993-11-02 | Warner-Lambert Company | Individual stereoisomers of pyrrolidine methanamines substituted on the ring nitrogen by a 1-phenylethyl group |
| US5364861A (en) | 1990-11-30 | 1994-11-15 | Warner-Lambert Company | Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents |
| US5072001A (en) | 1990-11-30 | 1991-12-10 | Warner-Lambert Company | Certain optically active substituted 3-pyrraidine acetic acid derivatives useful as intermediates |
| DE4120646A1 (de) | 1991-06-22 | 1992-12-24 | Bayer Ag | 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate |
| DE4123918A1 (de) | 1991-07-19 | 1993-01-21 | Bayer Ag | 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren |
| KR930703292A (ko) | 1991-12-27 | 1993-11-29 | 쿠사이 요시히로 | 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제 |
| EP0550016A1 (en) | 1991-12-31 | 1993-07-07 | Korea Research Institute Of Chemical Technology | Novel quinolone carboxylic acid derivatives and processes for preparing same |
| NO304832B1 (no) | 1992-05-27 | 1999-02-22 | Ube Industries | Aminokinolonderivater samt middel mot HIV |
| DE4230804A1 (de) | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
| DE4234078A1 (de) | 1992-10-09 | 1994-04-14 | Bayer Ag | Chinoloncarbonsäuren |
| KR0148277B1 (ko) | 1993-01-18 | 1998-11-02 | 채영복 | 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법 |
| DE4301246A1 (de) | 1993-01-19 | 1994-07-21 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäurederivate |
| DE4301245A1 (de) | 1993-01-19 | 1994-07-21 | Bayer Ag | Fluor-trifluormethylbenzoesäure-Derivate |
| CA2152828A1 (en) | 1993-03-16 | 1994-07-07 | Shin-Ichi Uesato | 8-methoxy-quinolonecarboxylic acid derivatives |
| TW252107B (ja) | 1993-08-27 | 1995-07-21 | Hokuriku Pharmacetical Co Ltd | |
| WO1995010519A1 (en) | 1993-10-14 | 1995-04-20 | Abbott Laboratories | Quinolizinone type compounds |
| NZ290946A (en) | 1994-08-12 | 1997-12-19 | Toyama Chemical Co Ltd | Quinolone- or naphthyridone-carboxylic acid derivatives |
| CA2212226A1 (en) | 1995-02-02 | 1995-08-10 | Katsumi Chiba | Bicyclic amino group-substituted pyridonecarboxylic acid derivatives, esters thereof and salts thereof, and bicyclic amines useful as intermediates thereof |
| WO1996023782A1 (fr) | 1995-02-02 | 1996-08-08 | Daiichi Pharmaceutical Co., Ltd. | Composes heterocycliques |
| JP3745433B2 (ja) | 1995-02-02 | 2006-02-15 | 第一製薬株式会社 | 複素環式化合物 |
| DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
| CA2222322A1 (en) | 1995-06-06 | 1996-12-12 | Abbott Laboratories | Quinolizinone type compounds |
| IT1279532B1 (it) | 1995-07-24 | 1997-12-16 | Mediolanum Farmaceutici Spa | Derivati chinolonici non fluorurati e loro impiego come agenti antibatterici |
| CN1119343C (zh) | 1995-11-22 | 2003-08-27 | 第一制药株式会社 | 取代的氨基环烷基吡咯烷衍生物 |
| KR100531967B1 (ko) | 1996-10-25 | 2005-11-30 | 다이이찌 세이야꾸 가부시기가이샤 | 트리사이클릭 아민 유도체, 이를 포함하는 항균제 및 퀴놀론 화합물의 제조방법 |
| US6274592B1 (en) | 1997-02-04 | 2001-08-14 | Senju Pharmaceutical Co., Ltd. | Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid |
| AU7449398A (en) | 1997-05-21 | 1998-12-11 | Daiichi Pharmaceutical Co., Ltd. | Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives |
| MY119816A (en) | 1997-05-30 | 2005-07-29 | Daiichi Seiyaku Co | Substituted cyclobutylamine derivatives |
| KR100241673B1 (ko) | 1997-08-09 | 2000-03-02 | 김충섭 | 퀴놀리진 카르복실산 유도체 |
| US6387928B1 (en) | 1997-09-15 | 2002-05-14 | The Procter & Gamble Co. | Antimicrobial quinolones, their compositions and uses |
| WO1999014214A1 (en) | 1997-09-15 | 1999-03-25 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
| GB9822440D0 (en) | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
| GB9914486D0 (en) | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
| US7094780B1 (en) | 2000-01-24 | 2006-08-22 | Warner Lambert Company Llc | 3-aminoquinazolin-2,4-dione antibacterial agents |
| AU3089102A (en) | 2000-12-14 | 2002-06-24 | Procter & Gamble | Antimicrobial quinolones |
| JP4250353B2 (ja) | 2001-06-22 | 2009-04-08 | エドワーズ株式会社 | 真空ポンプ |
| US6900224B2 (en) | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
| US6803469B2 (en) | 2002-08-05 | 2004-10-12 | The Procter & Gamble Company | Process for preparing quinolone antibiotic intermediates |
| AU2004278320B2 (en) * | 2003-09-22 | 2010-06-24 | Janssen Pharmaceutica, N.V. | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| US7732612B2 (en) | 2004-09-09 | 2010-06-08 | Janssen Pharmaceutica, N.V. | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| MX2008012488A (es) | 2006-03-28 | 2008-10-10 | Procter & Gamble | Un proceso de acoplamiento para preparar intermedios de quinolona. |
| CA2647457C (en) * | 2006-03-28 | 2011-05-24 | The Procter & Gamble Company | A hydride reduction process for preparing quinolone intermediates |
-
2007
- 2007-03-26 SM SM200800058T patent/SMP200800058B/it unknown
- 2007-03-26 AT AT07735261T patent/ATE507219T1/de active
- 2007-03-26 CA CA2647346A patent/CA2647346C/en active Active
- 2007-03-26 JP JP2009502298A patent/JP5097967B2/ja active Active
- 2007-03-26 MX MX2008012328A patent/MX2008012328A/es active IP Right Grant
- 2007-03-26 DK DK07735261.5T patent/DK2001862T3/da active
- 2007-03-26 US US11/728,343 patent/US8039485B2/en active Active
- 2007-03-26 NZ NZ570494A patent/NZ570494A/en unknown
- 2007-03-26 EP EP07735261A patent/EP2001862B1/en active Active
- 2007-03-26 BR BRPI0709772A patent/BRPI0709772B8/pt active IP Right Grant
- 2007-03-26 WO PCT/IB2007/051055 patent/WO2007110834A2/en active Application Filing
- 2007-03-26 KR KR1020087023397A patent/KR101102288B1/ko active IP Right Grant
- 2007-03-26 SI SI200730599T patent/SI2001862T1/sl unknown
- 2007-03-26 PL PL07735261T patent/PL2001862T3/pl unknown
- 2007-03-26 AU AU2007230630A patent/AU2007230630B2/en active Active
- 2007-03-26 ES ES07735261T patent/ES2366150T3/es active Active
- 2007-03-26 MY MYPI20083531A patent/MY148393A/en unknown
- 2007-03-26 DE DE602007014191T patent/DE602007014191D1/de active Active
- 2007-03-26 PT PT07735261T patent/PT2001862E/pt unknown
- 2007-03-27 TW TW096110617A patent/TWI364419B/zh active
- 2007-03-28 AR ARP070101308A patent/AR060189A1/es not_active Application Discontinuation
- 2007-03-28 PE PE2007000348A patent/PE20080175A1/es active IP Right Grant
- 2007-04-09 AR ARP070101472A patent/AR060377A1/es not_active Application Discontinuation
-
2008
- 2008-08-19 ZA ZA200807158A patent/ZA200807158B/xx unknown
- 2008-09-09 IL IL193990A patent/IL193990A/en active IP Right Grant
- 2008-10-15 MA MA31295A patent/MA30554B1/fr unknown
-
2011
- 2011-07-11 CY CY20111100668T patent/CY1111683T1/el unknown
- 2011-07-26 HR HR20110558T patent/HRP20110558T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110558T1 (hr) | Malatne soli i polimorfi od (3s, 5s)-7-[3-amino-5-metil-piperidinil]-1-ciklopropil-1, 4-dihidro-8-metoksi-4-okso-3-kinolinkarboksilne kiseline | |
| HRP20151000T1 (hr) | Antivirusni spojevi | |
| HRP20191000T1 (hr) | Spojevi za vezanje nhe3 i metode inhibiranja transporta fosfata | |
| HRP20210343T1 (hr) | Soli ili ko-kristali 3-(3-dimetilamino-1-etil-2-metil-propil)-fenola | |
| HRP20171197T1 (hr) | Bifenilsulfonamidni antagonist receptora endotelina i angiotensina ii, namijenjen liječenju glomeruloskleroze | |
| HRP20180455T1 (hr) | Natrijev (2r, 5s, 13ar) -7, 9-diokso-10- ( (2,4,6-trifluorobenzil) karbamoil) -2, 3, 4, 5, 7, 9, 13, 13a-oktahidro-2, 5-metanopirido [1’,2’ : 4.5]pirazino [2,1-b]oksazepin-8-olat | |
| HRP20201243T1 (hr) | N-piperidinil acetamidni derivati kao blokatori kalcijevog kanala | |
| HRP20140011T1 (hr) | Derivati oksazina i njihova uporaba u lijeäśenju neuroloških poremeä†aja | |
| HRP20161742T1 (hr) | Soli i polimorfi od 8-fluoro-2-{4-[(metilamino)metil]fenil}-1,3,4,5-tetrahidro-6h-azepino[5,4,3-cd]indol-6-ona | |
| HRP20120803T1 (hr) | Prolijekovi alkilatora fosforamidata | |
| RU2009123936A (ru) | Кристаллические формы золендроновой кислоты | |
| HRP20150982T1 (hr) | Novi modulatori sfingozin fosfat receptora | |
| SI2010528T1 (en) | 6-O-substituted benzoxazole and benzothiazole compounds and procedures for inhibiting CSF-1R signaling | |
| HRP20120700T1 (hr) | SOLI SPOJEVA INHIBITORA HIV-a | |
| BR112015022077A2 (pt) | composto de pirazol-amida e usos medicinais do mesmo | |
| HRP20120793T1 (hr) | Kristalni oblici nilotinib hci | |
| BR112015015477A2 (pt) | derivados de 2,3-di-hidro-isoindol-1-ona e métodos de uso dos mesmos como inibidores de btk | |
| HK1156847A1 (en) | Pharmaceutical formulations and methods for treating respiratory tract infections | |
| RS54329B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS | |
| HRP20150531T1 (hr) | Pirazolilaminopiridini kao inhibitori fak | |
| FI3702351T3 (fi) | MEK-inhibiittorin käsittävä koostumus | |
| CA2736751A1 (en) | Salts of n-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide | |
| HRP20140896T1 (hr) | (-)-stereoizomer 2,6-di-sec-butilfenola i njegovi analozi za poticanje antiemetskog uäśinka, lijeäśenje muäśnine i povraä†anja, te lijeäśenje migrene | |
| HRP20151340T1 (hr) | Derivati tieno[2,3-d] pirimidina i njihova primjena u lijeäśenju aritmije | |
| BR112015025058A2 (pt) | composição farmacêutica capaz de controlar facilmente o padrão de dissolução de lacosamida ou de um sal farmaceuticamente aceitável da mesma |